Thermo Fisher Scientific to establish bioprocess design centre in Hyderabad, boosting local pharmaceutical industry with ...

NEW DELHI: Seeking to tap the vast potential of seaweeds in India, the Centre has for the first time come out with guidelines for import of live seaweed that will be used to increase its production in ...

In the Philippines, where 8 out of 10 cardiac arrests occur outside hospitals, most often in the homes, with family members nearby but with little to no knowledge of lifesaving skills, being prepared ...

The U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- ...

Financial writer's analysis on Thermo Fisher Scientific Inc. upgrade to Buy, citing growth potential in the pharma and ...

Novo Nordisk has nominated semaglutide for inclusion in the FDA’s Demonstrable Difficulties for Compounding list, which ...

Pfizer’s Abrysvo is the first respiratory syncytial virus vaccine that can be used for adults less than 50 years of age.

According to OKYO Pharma, OK-101 is the first drug candidate to enroll patients specifically diagnosed with neuropathic ...

The CEO of pharmaceuticals giant Roche said authorities should block the takeover of contract drug manufacturer Catalent by ...

Shares of Lumos Pharma rallied after investment firm Double Point Ventures agreed to buy the biopharmaceutical company for $38 million in cash plus potential milestone payments. Lumos shares rose 12% ...

The future of health care starts on Jan. 20, 2025. The stakes for Americans could not be higher. Whether it’s Vice President Kamala Harris or former President Donald Trump in the White House that day, ...

Global drug shortages underscore the pharmaceutical industry's reliance on fragile supply chains, highlighting the urgent ...